{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T14:45:33Z","timestamp":1792075533050,"version":"4.4.0"},"reference-count":108,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Neurobiol"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1007\/s12035-026-06265-1","type":"journal-article","created":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T12:16:31Z","timestamp":1792066591000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Restoring Neural Homeostasis via Class II HDAC Modulation: Mechanistic Insights and Therapeutic Opportunities"],"prefix":"10.1007","volume":"63","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6635-6558","authenticated-orcid":false,"given":"Rohan","family":"Gupta","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reetesh","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bhargav Shreevatsa","family":"K. S.","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deepak Kumar","family":"Modi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Smita","family":"Kumari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naveen","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pallavi","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karthikeyan","family":"Ravi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mosleh Mohammad","family":"Abomughaid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,10,15]]},"reference":[{"key":"6265_CR1","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1038\/s41392-025-02145-7","volume":"10","author":"Q Jiang","year":"2025","unstructured":"Jiang Q, Liu J, Huang S et al (2025) Antiageing strategy for neurodegenerative diseases: from mechanisms to clinical advances. Sig Transduct Target Ther 10:76. https:\/\/doi.org\/10.1038\/s41392-025-02145-7","journal-title":"Sig Transduct Target Ther"},{"key":"6265_CR2","doi-asserted-by":"publisher","first-page":"1651","DOI":"10.1111\/bph.16078","volume":"180","author":"AG de la Fuente","year":"2023","unstructured":"de la Fuente AG, Pelucchi S, Mertens J et al (2023) Novel therapeutic approaches to target neurodegeneration. Br J Pharmacol 180:1651\u20131673. https:\/\/doi.org\/10.1111\/bph.16078","journal-title":"Br J Pharmacol"},{"key":"6265_CR3","doi-asserted-by":"publisher","unstructured":"Lossi L, Castagna C, Merighi A et al (2024) An overview of the epigenetic modifications in the brain under normal and pathological conditions. Int J Mol Sci 25. https:\/\/doi.org\/10.3390\/ijms25073881","DOI":"10.3390\/ijms25073881"},{"key":"6265_CR4","doi-asserted-by":"publisher","unstructured":"Curcio A, Rocca R, Alcaro S et al (2024) The histone deacetylase family: structural features and application of combined computational methods. Pharmaceuticals 17. https:\/\/doi.org\/10.3390\/ph17050620","DOI":"10.3390\/ph17050620"},{"key":"6265_CR5","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1080\/14728222.2018.1465930","volume":"22","author":"A Saavedra","year":"2018","unstructured":"Saavedra A, Garc\u00eda-D\u00edaz Barriga G, P\u00e9rez-Navarro E, Alberch J (2018) Huntington\u2019s disease: novel therapeutic perspectives hanging in the balance. Expert Opin Ther Targets 22:385\u2013399. https:\/\/doi.org\/10.1080\/14728222.2018.1465930","journal-title":"Expert Opin Ther Targets"},{"key":"6265_CR6","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1038\/s41392-022-01245-y","volume":"7","author":"S Shang","year":"2022","unstructured":"Shang S, Liu J, Hua F (2022) Protein acylation: mechanisms, biological functions and therapeutic targets. Sig Transduct Target Ther 7:396. https:\/\/doi.org\/10.1038\/s41392-022-01245-y","journal-title":"Sig Transduct Target Ther"},{"key":"6265_CR7","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2024.107410","volume":"208","author":"L-Y Zhang","year":"2024","unstructured":"Zhang L-Y, Zhang S-Y, Wen R et al (2024) Role of histone deacetylases and their inhibitors in neurological diseases. Pharmacol Res 208:107410. https:\/\/doi.org\/10.1016\/j.phrs.2024.107410","journal-title":"Pharmacol Res"},{"key":"6265_CR8","doi-asserted-by":"publisher","DOI":"10.3390\/ph18101471","author":"PdeSM Pinheiro","year":"2025","unstructured":"Pinheiro PdeSM, Diniz LP, Franco LS et al (2025) Histone deacetylases in neurodegenerative diseases and their potential role as therapeutic targets: shedding light on astrocytes. Pharmaceuticals (Basel). https:\/\/doi.org\/10.3390\/ph18101471","journal-title":"Pharmaceuticals (Basel)"},{"key":"6265_CR9","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1038\/s41392-026-02764-8","volume":"11","author":"R Wen","year":"2026","unstructured":"Wen R, Yang Y-H, Zhang T et al (2026) The histone deacetylase family in health and disease. Sig Transduct Target Ther 11:381. https:\/\/doi.org\/10.1038\/s41392-026-02764-8","journal-title":"Sig Transduct Target Ther"},{"key":"6265_CR10","doi-asserted-by":"publisher","DOI":"10.1016\/j.cclet.2025.112263","author":"H Li","year":"2025","unstructured":"Li H, Zhao Y-X, Niu J-B et al (2025) Hydrazide-based HDAC inhibitors and PROTAC degraders in drug discovery: recent developments and therapeutic applications. Chin Chem Lett. https:\/\/doi.org\/10.1016\/j.cclet.2025.112263","journal-title":"Chin Chem Lett"},{"key":"6265_CR11","doi-asserted-by":"publisher","DOI":"10.3390\/cells14171338","author":"LP Diniz","year":"2025","unstructured":"Diniz LP, Pinheiro PdeSM, Franco LS et al (2025) HDACs in the brain: from chromatin remodeling to neurodegenerative disease. Cells. https:\/\/doi.org\/10.3390\/cells14171338","journal-title":"Cells"},{"key":"6265_CR12","doi-asserted-by":"publisher","unstructured":"Brancolini C (2025) Class IIa HDACs are important signal transducers with unclear enzymatic activities. Biomolecules 15. https:\/\/doi.org\/10.3390\/biom15081061","DOI":"10.3390\/biom15081061"},{"key":"6265_CR13","doi-asserted-by":"publisher","DOI":"10.1007\/s00395-021-00850-2","volume":"116","author":"KG Helmstadter","year":"2021","unstructured":"Helmstadter KG, Ljubojevic-Holzer S, Wood BM et al (2021) CaMKII and PKA-dependent phosphorylation co-regulate nuclear localization of HDAC4 in adult cardiomyocytes. Basic Res Cardiol 116:11. https:\/\/doi.org\/10.1007\/s00395-021-00850-2","journal-title":"Basic Res Cardiol"},{"key":"6265_CR14","doi-asserted-by":"publisher","first-page":"3469","DOI":"10.1038\/s41467-019-11409-0","volume":"10","author":"Y Zhu","year":"2019","unstructured":"Zhu Y, Huang M, Bushong E et al (2019) Class IIa HDACs regulate learning and memory through dynamic experience-dependent repression of transcription. Nat Commun 10:3469. https:\/\/doi.org\/10.1038\/s41467-019-11409-0","journal-title":"Nat Commun"},{"key":"6265_CR15","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1186\/s40364-024-00687-6","volume":"12","author":"D-F Cao","year":"2024","unstructured":"Cao D-F, Zhou X-Y, Guo Q et al (2024) Unveiling the role of histone deacetylases in neurological diseases: focus on epilepsy. Biomark Res 12:142. https:\/\/doi.org\/10.1186\/s40364-024-00687-6","journal-title":"Biomark Res"},{"key":"6265_CR16","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-024-65094-1","volume":"14","author":"N Bahram Sangani","year":"2024","unstructured":"Bahram Sangani N, Koetsier J, M\u00e9lius J et al (2024) A novel insight into neurological disorders through HDAC6 protein\u2013protein interactions. Sci Rep 14:14666. https:\/\/doi.org\/10.1038\/s41598-024-65094-1","journal-title":"Sci Rep"},{"key":"6265_CR17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3892\/ijmm.2025.5578","volume":"56","author":"F Qu","year":"2025","unstructured":"Qu F, Zhao Q, Jin Y (2025) Histone deacetylase 6: a new player in oxidative stress-associated disorders and cancers (review). Int J Mol Med 56:1\u201318. https:\/\/doi.org\/10.3892\/ijmm.2025.5578","journal-title":"Int J Mol Med"},{"key":"6265_CR18","doi-asserted-by":"publisher","first-page":"2154","DOI":"10.1021\/acschembio.0c00362","volume":"15","author":"CJ Herbst-Gervasoni","year":"2020","unstructured":"Herbst-Gervasoni CJ, Steimbach RR, Morgen M et al (2020) Structural basis for the selective inhibition of HDAC10, the cytosolic polyamine deacetylase. ACS Chem Biol 15:2154\u20132163. https:\/\/doi.org\/10.1021\/acschembio.0c00362","journal-title":"ACS Chem Biol"},{"key":"6265_CR19","doi-asserted-by":"publisher","DOI":"10.1016\/j.ecoenv.2024.116841","volume":"283","author":"A Qi","year":"2024","unstructured":"Qi A, Wang K, Li Y et al (2024) The degradation of \u03b1\u2013synuclein is limited by dynein to drive the AALP pathway through HDAC6 upon paraquat exposure. Ecotoxicol Environ Saf 283:116841. https:\/\/doi.org\/10.1016\/j.ecoenv.2024.116841","journal-title":"Ecotoxicol Environ Saf"},{"key":"6265_CR20","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1038\/s12276-020-0382-4","volume":"52","author":"S-Y Park","year":"2020","unstructured":"Park S-Y, Kim J-S (2020) A short guide to histone deacetylases including recent progress on class II enzymes. Exp Mol Med 52:204\u2013212. https:\/\/doi.org\/10.1038\/s12276-020-0382-4","journal-title":"Exp Mol Med"},{"key":"6265_CR21","doi-asserted-by":"publisher","DOI":"10.1016\/j.redox.2024.103457","volume":"79","author":"K-Y Pham","year":"2025","unstructured":"Pham K-Y, Khanal S, Bohara G et al (2025) HDAC6 inhibitor-loaded brain-targeted nanocarrier-mediated neuroprotection in methamphetamine-driven Parkinson\u2019s disease. Redox Biol 79:103457. https:\/\/doi.org\/10.1016\/j.redox.2024.103457","journal-title":"Redox Biol"},{"key":"6265_CR22","doi-asserted-by":"publisher","unstructured":"Liang Y, Wang Y, Xing J et al (2025) The regulatory mechanisms and treatment of HDAC6 in immune dysregulation diseases. Front Immunol 16. https:\/\/doi.org\/10.3389\/fimmu.2025.1653588","DOI":"10.3389\/fimmu.2025.1653588"},{"key":"6265_CR23","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms15368","volume":"8","author":"Y Hai","year":"2017","unstructured":"Hai Y, Shinsky SA, Porter NJ, Christianson DW (2017) Histone deacetylase 10 structure and molecular function as a polyamine deacetylase. Nat Commun 8:15368. https:\/\/doi.org\/10.1038\/ncomms15368","journal-title":"Nat Commun"},{"key":"6265_CR24","doi-asserted-by":"publisher","unstructured":"Taylor CA, Maor-Nof M, Metzl-Raz E et al (2024) Histone deacetylase inhibition expands cellular proteostasis repertoires to enhance neuronal stress resilience. https:\/\/doi.org\/10.1101\/2024.08.21.608176","DOI":"10.1101\/2024.08.21.608176"},{"key":"6265_CR25","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1021\/acschembio.4c00753","volume":"20","author":"IKM Kodikara","year":"2025","unstructured":"Kodikara IKM, Pflum MKH (2025) Scaffolding activities of pseudodeacetylase HDAC7. ACS Chem Biol 20:248\u2013258. https:\/\/doi.org\/10.1021\/acschembio.4c00753","journal-title":"ACS Chem Biol"},{"key":"6265_CR26","doi-asserted-by":"publisher","first-page":"2711","DOI":"10.1093\/nar\/gkae036","volume":"52","author":"S Dai","year":"2024","unstructured":"Dai S, Guo L, Dey R et al (2024) Structural insights into the HDAC4\u2013MEF2A\u2013DNA complex and its implication in long-range transcriptional regulation. Nucleic Acids Res 52:2711\u20132723. https:\/\/doi.org\/10.1093\/nar\/gkae036","journal-title":"Nucleic Acids Res"},{"key":"6265_CR27","doi-asserted-by":"publisher","first-page":"5609","DOI":"10.1007\/s12035-024-04598-3","volume":"62","author":"R de Andr\u00e9s","year":"2025","unstructured":"de Andr\u00e9s R, Mart\u00ednez-Blanco E, D\u00edez-Guerra FJ (2025) HDAC4 inhibits NMDA receptor-mediated stimulation of neurogranin expression. Mol Neurobiol 62:5609\u20135628. https:\/\/doi.org\/10.1007\/s12035-024-04598-3","journal-title":"Mol Neurobiol"},{"key":"6265_CR28","doi-asserted-by":"publisher","DOI":"10.1111\/nan.12861","volume":"49","author":"C Colussi","year":"2023","unstructured":"Colussi C, Aceto G, Ripoli C et al (2023) Cytoplasmic HDAC4 recovers synaptic function in the 3\u00d7Tg mouse model of Alzheimer\u2019s disease. Neuropathol Appl Neurobiol 49:e12861. https:\/\/doi.org\/10.1111\/nan.12861","journal-title":"Neuropathol Appl Neurobiol"},{"key":"6265_CR29","doi-asserted-by":"publisher","unstructured":"Hawley HR, Sutherland-Smith AJ, Savoian MS, Fitzsimons HL (2025) N-terminal oligomerization drives HDAC4 nuclear condensation and neurodevelopmental dysfunction in Drosophila.15(10):250095. https:\/\/doi.org\/10.1098\/rsob.250095","DOI":"10.1098\/rsob.250095"},{"key":"6265_CR30","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1016\/j.tig.2024.12.008","volume":"41","author":"N Sugo","year":"2025","unstructured":"Sugo N, Atsumi Y, Yamamoto N (2025) Transcription and epigenetic factor dynamics in neuronal activity-dependent gene regulation. Trends Genet 41:425\u2013436. https:\/\/doi.org\/10.1016\/j.tig.2024.12.008","journal-title":"Trends Genet"},{"key":"6265_CR31","doi-asserted-by":"publisher","first-page":"942","DOI":"10.1038\/s41386-023-01775-1","volume":"49","author":"X Dai","year":"2024","unstructured":"Dai X, Lin A, Zhuang L et al (2024) Targeting SIK3 to modulate hippocampal synaptic plasticity and cognitive function by regulating the transcription of HDAC4 in a mouse model of Alzheimer\u2019s disease. Neuropsychopharmacol 49:942\u2013952. https:\/\/doi.org\/10.1038\/s41386-023-01775-1","journal-title":"Neuropsychopharmacol"},{"key":"6265_CR32","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.neuroscience.2024.08.010","volume":"557","author":"N Li","year":"2024","unstructured":"Li N, Liu T, Wang Y-Y et al (2024) Hippocampal HDAC5-mediated histone acetylation underlies stress susceptibility in mice exposed to chronic social defeat stress. Neuroscience 557:89\u201399. https:\/\/doi.org\/10.1016\/j.neuroscience.2024.08.010","journal-title":"Neuroscience"},{"key":"6265_CR33","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1007\/s00018-023-04945-y","volume":"80","author":"Y Dai","year":"2023","unstructured":"Dai Y, Wei T, Huang Y et al (2023) Upregulation of HDAC9 in hippocampal neurons mediates depression-like behaviours by inhibiting ANXA2 degradation. Cell Mol Life Sci 80:289. https:\/\/doi.org\/10.1007\/s00018-023-04945-y","journal-title":"Cell Mol Life Sci"},{"key":"6265_CR34","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2024.e34587","volume":"10","author":"AJ Phipps","year":"2024","unstructured":"Phipps AJ, Dwyer S, Collins JM et al (2024) HDAC6 inhibition as a mechanism to prevent neurodegeneration in the mSOD1G93A mouse model of ALS. Heliyon 10:e34587. https:\/\/doi.org\/10.1016\/j.heliyon.2024.e34587","journal-title":"Heliyon"},{"key":"6265_CR35","doi-asserted-by":"publisher","DOI":"10.1007\/s12035-025-05385-4","volume":"63","author":"S Rivas","year":"2025","unstructured":"Rivas S, Esquivel L, Busso J et al (2025) HDAC6 inhibition drives synaptic protein acetylation and enhances long-term memory in mice. Mol Neurobiol 63:123. https:\/\/doi.org\/10.1007\/s12035-025-05385-4","journal-title":"Mol Neurobiol"},{"key":"6265_CR36","doi-asserted-by":"publisher","first-page":"1373","DOI":"10.1080\/17501911.2024.2419357","volume":"16","author":"C Rosete","year":"2024","unstructured":"Rosete C, Ciernia AV (2024) The two faces of HDAC3: neuroinflammation in disease and neuroprotection in recovery. Epigenomics 16:1373\u20131388. https:\/\/doi.org\/10.1080\/17501911.2024.2419357","journal-title":"Epigenomics"},{"key":"6265_CR37","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-11409-0","volume":"10","author":"Y Zhu","year":"2019","unstructured":"Zhu Y, Huang M, Bushong E et al (2019) Class IIa HDACs regulate learning and memory through dynamic experience-dependent repression of transcription. Nat Commun 10:3469. https:\/\/doi.org\/10.1038\/s41467-019-11409-0","journal-title":"Nat Commun"},{"key":"6265_CR38","doi-asserted-by":"publisher","unstructured":"Rinc\u00f3n RF, Coira I, Richieu A et al (2025) Selective molecular inhibition of the HDAC6 ZnF-UBP binding domain impairs multiple myeloma cell function. Cell Death Discov 11:176. https:\/\/doi.org\/10.1038\/s41420-025-02465-1","DOI":"10.1038\/s41420-025-02465-1"},{"key":"6265_CR39","doi-asserted-by":"publisher","DOI":"10.3390\/cells14120873","volume":"14","author":"HA Mai","year":"2025","unstructured":"Mai HA, Thomas CM, Nge GG, Elefant F (2025) Modulating cognition-linked histone acetyltransferases (HATs) as a therapeutic strategy for neurodegenerative diseases: recent advances and future trends. Cells 14:873. https:\/\/doi.org\/10.3390\/cells14120873","journal-title":"Cells"},{"key":"6265_CR40","doi-asserted-by":"publisher","first-page":"6249","DOI":"10.1021\/acs.jcim.5c00858","volume":"65","author":"N Gautam","year":"2025","unstructured":"Gautam N, Wang S, \u00dcren A et al (2025) Mapping the interactions among class IIa histone deacetylases and myocyte enhancer factor 2s. J Chem Inf Model 65:6249\u20136260. https:\/\/doi.org\/10.1021\/acs.jcim.5c00858","journal-title":"J Chem Inf Model"},{"key":"6265_CR41","doi-asserted-by":"publisher","unstructured":"Mitrovic M, Selakovic D, Jovicic N et al (2025) BDNF\/proBDNF interplay in the mediation of neuronal apoptotic mechanisms in neurodegenerative diseases. Int J Mol Sci 26. https:\/\/doi.org\/10.3390\/ijms26104926","DOI":"10.3390\/ijms26104926"},{"key":"6265_CR42","doi-asserted-by":"publisher","DOI":"10.3390\/biom16010103","volume":"16","author":"Y Pawar","year":"2026","unstructured":"Pawar Y, Kopranovic A, C S R, Meyer-Almes F-J (2026) Epigenetic dysregulation in neurodegeneration: the role of histone deacetylases and emerging inhibitor strategies. Biomolecules 16:103. https:\/\/doi.org\/10.3390\/biom16010103","journal-title":"Biomolecules"},{"key":"6265_CR43","doi-asserted-by":"publisher","unstructured":"Zhang W, Zhang Y, Wang Y et al (2025) Advancing histone deacetylase 6 (HDAC6) as a promising therapeutic target for Alzheimer\u2019s disease: from molecular insights to clinical prospects. Front Drug Discov 5. https:\/\/doi.org\/10.3389\/fddsv.2025.1662691","DOI":"10.3389\/fddsv.2025.1662691"},{"key":"6265_CR44","doi-asserted-by":"publisher","first-page":"6904","DOI":"10.1128\/mcb.20.18.6904-6912.2000","volume":"20","author":"AH Wang","year":"2000","unstructured":"Wang AH, Kruhlak MJ, Wu J et al (2000) Regulation of histone deacetylase 4 by binding of 14\u20133-3 proteins. Mol Cell Biol 20:6904\u20136912. https:\/\/doi.org\/10.1128\/mcb.20.18.6904-6912.2000","journal-title":"Mol Cell Biol"},{"key":"6265_CR45","doi-asserted-by":"publisher","unstructured":"Safaei Z, Thompson GL (2022) Histone deacetylase 4 and 5 translocation elicited by microsecond pulsed electric field exposure is mediated by kinase activity. Front Bioeng Biotechnol 10. https:\/\/doi.org\/10.3389\/fbioe.2022.1047851","DOI":"10.3389\/fbioe.2022.1047851"},{"key":"6265_CR46","doi-asserted-by":"publisher","first-page":"2081","DOI":"10.1177\/0271678X19884742","volume":"40","author":"L Formisano","year":"2020","unstructured":"Formisano L, Laudati G, Guida N et al (2020) HDAC4 and HDAC5 form a complex with DREAM that epigenetically down-regulates NCX3 gene and its pharmacological inhibition reduces neuronal stroke damage. J Cereb Blood Flow Metab 40:2081\u20132097. https:\/\/doi.org\/10.1177\/0271678X19884742","journal-title":"J Cereb Blood Flow Metab"},{"key":"6265_CR47","doi-asserted-by":"publisher","first-page":"1362","DOI":"10.1021\/acs.jmedchem.0c01782","volume":"64","author":"X-H Zhang","year":"2021","unstructured":"Zhang X-H, Qin-Ma W-P et al (2021) A review of progress in histone deacetylase 6 inhibitors research: structural specificity and functional diversity. J Med Chem 64:1362\u20131391. https:\/\/doi.org\/10.1021\/acs.jmedchem.0c01782","journal-title":"J Med Chem"},{"key":"6265_CR48","doi-asserted-by":"publisher","DOI":"10.3389\/fnmol.2021.616642","volume":"14","author":"P Main","year":"2021","unstructured":"Main P, Tan WJ, Wheeler D, Fitzsimons HL (2021) Increased abundance of nuclear HDAC4 impairs neuronal development and long-term memory. Front Mol Neurosci 14:616642. https:\/\/doi.org\/10.3389\/fnmol.2021.616642","journal-title":"Front Mol Neurosci"},{"key":"6265_CR49","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.4103\/1673-5374.386407","volume":"19","author":"H K\u00f6rschgen","year":"2024","unstructured":"K\u00f6rschgen H, Behl C (2024) Aggresome-aggrephagy transition process: getting closer to the functional roles of HDAC6 and BAG3. Neural Regen Res 19:1181. https:\/\/doi.org\/10.4103\/1673-5374.386407","journal-title":"Neural Regen Res"},{"key":"6265_CR50","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.1092-25.2025","author":"A Crowe","year":"2025","unstructured":"Crowe A, Yao Y, Newman M et al (2025) HDAC6 inhibition reduces seeded tau and \u03b1-synuclein pathologies in primary neuron cultures and wild-type mice. J Neurosci. https:\/\/doi.org\/10.1523\/JNEUROSCI.1092-25.2025","journal-title":"J Neurosci"},{"key":"6265_CR51","doi-asserted-by":"publisher","first-page":"6141","DOI":"10.1007\/s12035-022-02965-6","volume":"59","author":"J Ye","year":"2022","unstructured":"Ye J, Zhong S, Deng Y et al (2022) HDAC7 activates IKK\/NF-\u03baB signaling to regulate astrocyte-mediated inflammation. Mol Neurobiol 59:6141\u20136157. https:\/\/doi.org\/10.1007\/s12035-022-02965-6","journal-title":"Mol Neurobiol"},{"key":"6265_CR52","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2024.e33997","volume":"10","author":"C Zhou","year":"2024","unstructured":"Zhou C, Zhao D, Wu C et al (2024) Role of histone deacetylase inhibitors in non-neoplastic diseases. Heliyon 10:e33997. https:\/\/doi.org\/10.1016\/j.heliyon.2024.e33997","journal-title":"Heliyon"},{"key":"6265_CR53","doi-asserted-by":"publisher","unstructured":"Yue R, Guo X, Li W et al (2025) HDAC7 knockout mitigates astrocyte reactivity and neuroinflammation via the IRF3\/cGAS\/STING signaling pathway. Front Cell Neurosci 19. https:\/\/doi.org\/10.3389\/fncel.2025.1683595","DOI":"10.3389\/fncel.2025.1683595"},{"key":"6265_CR54","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1038\/s41392-025-02270-3","volume":"10","author":"P Jin","year":"2025","unstructured":"Jin P, Duan X, Huang Z et al (2025) Nuclear receptors in health and disease: signaling pathways, biological functions and pharmaceutical interventions. Sig Transduct Target Ther 10:228. https:\/\/doi.org\/10.1038\/s41392-025-02270-3","journal-title":"Sig Transduct Target Ther"},{"key":"6265_CR55","doi-asserted-by":"publisher","unstructured":"Sato K, Takayama K, Inoue S (2023) Expression and function of estrogen receptors and estrogen-related receptors in the brain and their association with Alzheimer\u2019s disease. Front Endocrinol 14. https:\/\/doi.org\/10.3389\/fendo.2023.1220150","DOI":"10.3389\/fendo.2023.1220150"},{"key":"6265_CR56","doi-asserted-by":"publisher","DOI":"10.3390\/antiox14081015","volume":"14","author":"M Lisek","year":"2025","unstructured":"Lisek M, Bochenska N, Tomczak J et al (2025) Epigenetic regulation in ischemic neuroprotection: the dual role of HDACs and HATs in neuroinflammation and recovery. Antioxidants (Basel) 14:1015. https:\/\/doi.org\/10.3390\/antiox14081015","journal-title":"Antioxidants (Basel)"},{"key":"6265_CR57","doi-asserted-by":"publisher","DOI":"10.1016\/j.mad.2026.112167","volume":"231","author":"E Marzetti","year":"2026","unstructured":"Marzetti E, Di Lorenzo R, Calvani R et al (2026) Mitochondrial quality in aging and neurodegeneration: the emerging role of mitochondria-derived vesicles. Mech Ageing Dev 231:112167. https:\/\/doi.org\/10.1016\/j.mad.2026.112167","journal-title":"Mech Ageing Dev"},{"key":"6265_CR58","doi-asserted-by":"publisher","unstructured":"Inoue Y, Ren Y, Zhang S et al (2024) A novel histone deacetylase inhibitor W2A-16 improves the barrier integrity in brain vascular endothelial cells. Front Cell Neurosci 18. https:\/\/doi.org\/10.3389\/fncel.2024.1368018","DOI":"10.3389\/fncel.2024.1368018"},{"key":"6265_CR59","doi-asserted-by":"publisher","DOI":"10.1111\/cns.14429","volume":"30","author":"C Peng","year":"2024","unstructured":"Peng C, Wang Y, Hu Z, Chen C (2024) Selective HDAC6 inhibition protects against blood\u2013brain barrier dysfunction after intracerebral hemorrhage. CNS Neurosci Ther 30:e14429. https:\/\/doi.org\/10.1111\/cns.14429","journal-title":"CNS Neurosci Ther"},{"key":"6265_CR60","doi-asserted-by":"publisher","unstructured":"Patil RS, Maloney ME, Lucas R et al (2024) Zinc-dependent histone deacetylases in lung endothelial pathobiology. Biomolecules 14. https:\/\/doi.org\/10.3390\/biom14020140","DOI":"10.3390\/biom14020140"},{"key":"6265_CR61","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2024.117295","volume":"179","author":"S-Y Zhang","year":"2024","unstructured":"Zhang S-Y, Zhang L-Y, Wen R et al (2024) Histone deacetylases and their inhibitors in inflammatory diseases. Biomed Pharmacother 179:117295. https:\/\/doi.org\/10.1016\/j.biopha.2024.117295","journal-title":"Biomed Pharmacother"},{"key":"6265_CR62","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/s12915-023-01800-1","volume":"22","author":"WJ Tan","year":"2024","unstructured":"Tan WJ, Hawley HR, Wilson SJ, Fitzsimons HL (2024) Deciphering the roles of subcellular distribution and interactions involving the MEF2 binding region, the ankyrin repeat binding motif and the catalytic site of HDAC4 in Drosophila neuronal morphogenesis. BMC Biol 22:2. https:\/\/doi.org\/10.1186\/s12915-023-01800-1","journal-title":"BMC Biol"},{"key":"6265_CR63","doi-asserted-by":"publisher","DOI":"10.1098\/rsob.250095","volume":"15","author":"HR Hawley","year":"2025","unstructured":"Hawley HR, Sutherland-Smith AJ, Savoian MS, Fitzsimons HL (2025) N-terminal oligomerization drives HDAC4 nuclear condensation and neurodevelopmental dysfunction in Drosophila. Open Biol 15:250095. https:\/\/doi.org\/10.1098\/rsob.25009","journal-title":"Open Biol"},{"key":"6265_CR64","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuropharm.2021.108893","volume":"204","author":"B Rein","year":"2022","unstructured":"Rein B, Conrow-Graham M, Frazier A et al (2022) Inhibition of histone deacetylase 5 ameliorates abnormalities in 16p11.2 duplication mouse model. Neuropharmacology 204:108893. https:\/\/doi.org\/10.1016\/j.neuropharm.2021.108893","journal-title":"Neuropharmacology"},{"key":"6265_CR65","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1297\/cpe.2022-0076","volume":"32","author":"S Takeyari","year":"2023","unstructured":"Takeyari S, Yamamoto K, Fujiwara M et al (2023) A family with brachydactyly mental retardation syndrome with a missense variant in HDAC4. Clin Pediatr Endocrinol (Tokyo) 32:105\u2013109. https:\/\/doi.org\/10.1297\/cpe.2022-0076","journal-title":"Clin Pediatr Endocrinol (Tokyo)"},{"key":"6265_CR66","doi-asserted-by":"publisher","unstructured":"Chen Y-A, Lu C-H, Ke C-C et al (2021) Evaluation of class IIa histone deacetylases expression and in vivo epigenetic imaging in a transgenic mouse model of Alzheimer\u2019s disease. Int J Mol Sci 22. https:\/\/doi.org\/10.3390\/ijms22168633","DOI":"10.3390\/ijms22168633"},{"key":"6265_CR67","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1186\/s40035-025-00482-9","volume":"14","author":"L Yuan","year":"2025","unstructured":"Yuan L, Mao L-H, Huang Y-Y et al (2025) Stress granules: emerging players in neurodegenerative diseases. Transl Neurodegener 14:22. https:\/\/doi.org\/10.1186\/s40035-025-00482-9","journal-title":"Transl Neurodegener"},{"key":"6265_CR68","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-94923-w","volume":"11","author":"T Onishi","year":"2021","unstructured":"Onishi T, Maeda R, Terada M et al (2021) A novel orally active HDAC6 inhibitor T-518 shows a therapeutic potential for Alzheimer\u2019s disease and tauopathy in mice. Sci Rep 11:15423. https:\/\/doi.org\/10.1038\/s41598-021-94923-w","journal-title":"Sci Rep"},{"key":"6265_CR69","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202304545","volume":"11","author":"P Mondal","year":"2024","unstructured":"Mondal P, Bai P, Gomm A et al (2024) Structure-based discovery of a small molecule inhibitor of histone deacetylase 6 (HDAC6) that significantly reduces Alzheimer\u2019s disease neuropathology. Adv Sci 11:2304545. https:\/\/doi.org\/10.1002\/advs.202304545","journal-title":"Adv Sci"},{"key":"6265_CR70","doi-asserted-by":"publisher","first-page":"6064","DOI":"10.1038\/s41598-020-62678-5","volume":"10","author":"L Francelle","year":"2020","unstructured":"Francelle L, Outeiro TF, Rappold GA (2020) Inhibition of HDAC6 activity protects dopaminergic neurons from alpha-synuclein toxicity. Sci Rep 10:6064. https:\/\/doi.org\/10.1038\/s41598-020-62678-5","journal-title":"Sci Rep"},{"key":"6265_CR71","doi-asserted-by":"publisher","unstructured":"Yan S, Wei X, Jian W et al (2020) Pharmacological inhibition of HDAC6 attenuates NLRP3 inflammatory response and protects dopaminergic neurons in experimental models of Parkinson\u2019s disease. Front Aging Neurosci 12. https:\/\/doi.org\/10.3389\/fnagi.2020.00078","DOI":"10.3389\/fnagi.2020.00078"},{"key":"6265_CR72","doi-asserted-by":"publisher","unstructured":"Mazzocchi M, Wyatt SL, Mercatelli D et al (2019) Gene co-expression analysis identifies histone deacetylase 5 and 9 expression in midbrain dopamine neurons and as regulators of neurite growth via bone morphogenetic protein signaling. Front Cell Dev Biol 7. https:\/\/doi.org\/10.3389\/fcell.2019.00191","DOI":"10.3389\/fcell.2019.00191"},{"key":"6265_CR73","doi-asserted-by":"publisher","unstructured":"Mazzocchi M, Collins LM, Sullivan AM, O\u2019Keeffe GW (2020) The class II histone deacetylases as therapeutic targets for Parkinson\u2019s disease. Neuronal Signal 4:NS20200001. https:\/\/doi.org\/10.1042\/NS20200001","DOI":"10.1042\/NS20200001"},{"key":"6265_CR74","doi-asserted-by":"publisher","DOI":"10.3389\/fnins.2020.00624","author":"S Mazzetti","year":"2020","unstructured":"Mazzetti S, De Leonardis M, Gagliardi G et al (2020) Phospho-HDAC6 gathers into protein aggregates in Parkinson\u2019s disease and atypical parkinsonisms. Front Neurosci. https:\/\/doi.org\/10.3389\/fnins.2020.00624","journal-title":"Front Neurosci"},{"key":"6265_CR75","doi-asserted-by":"publisher","DOI":"10.3389\/fnmol.2025.1579194","author":"A Reisbitzer","year":"2025","unstructured":"Reisbitzer A, Hollitzer C, Geraci A et al (2025) Inhibition of class IIa HDACs reduces mutant HTT aggregation by affecting RNA stability. Front Mol Neurosci. https:\/\/doi.org\/10.3389\/fnmol.2025.1579194","journal-title":"Front Mol Neurosci"},{"key":"6265_CR76","doi-asserted-by":"publisher","unstructured":"Pinheiro P de SM, Diniz LP, Franco LS et al (2025) Histone deacetylases in neurodegenerative diseases and their potential role as therapeutic targets: shedding light on astrocytes. Pharmaceuticals 18. https:\/\/doi.org\/10.3390\/ph18101471","DOI":"10.3390\/ph18101471"},{"key":"6265_CR77","doi-asserted-by":"publisher","first-page":"S92","DOI":"10.1074\/mcp.RA118.001253","volume":"18","author":"JD Federspiel","year":"2019","unstructured":"Federspiel JD, Greco TM, Lum KK, Cristea IM (2019) Hdac4 interactions in Huntington\u2019s disease viewed through the prism of multiomics *. Mol Cell Proteomics 18:S92\u2013S113. https:\/\/doi.org\/10.1074\/mcp.RA118.001253","journal-title":"Mol Cell Proteomics"},{"key":"6265_CR78","doi-asserted-by":"publisher","unstructured":"LoPresti P (2020) HDAC6 in diseases of cognition and of neurons. Cells 10. https:\/\/doi.org\/10.3390\/cells10010012","DOI":"10.3390\/cells10010012"},{"key":"6265_CR79","doi-asserted-by":"publisher","first-page":"178","DOI":"10.5483\/BMBRep.2022-0157","volume":"56","author":"E Li","year":"2023","unstructured":"Li E, Choi J, Sim H-R et al (2023) A novel HDAC6 inhibitor, CKD-504, is effective in treating preclinical models of Huntington\u2019s disease. BMB Rep 56:178\u2013183. https:\/\/doi.org\/10.5483\/BMBRep.2022-0157","journal-title":"BMB Rep"},{"key":"6265_CR80","doi-asserted-by":"publisher","first-page":"1353","DOI":"10.1111\/bph.15217","volume":"178","author":"YE Klingl","year":"2021","unstructured":"Klingl YE, Pakravan D, Van Den Bosch L (2021) Opportunities for histone deacetylase inhibition in amyotrophic lateral sclerosis. Br J Pharmacol 178:1353\u20131372. https:\/\/doi.org\/10.1111\/bph.15217","journal-title":"Br J Pharmacol"},{"key":"6265_CR81","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1016\/j.ebiom.2019.01.038","volume":"40","author":"E Pigna","year":"2019","unstructured":"Pigna E, Simonazzi E, Sanna K et al (2019) Histone deacetylase 4 protects from denervation and skeletal muscle atrophy in a murine model of amyotrophic lateral sclerosis. EBioMedicine 40:717\u2013732. https:\/\/doi.org\/10.1016\/j.ebiom.2019.01.038","journal-title":"EBioMedicine"},{"key":"6265_CR82","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1038\/s41573-022-00612-2","volume":"22","author":"RJ Mead","year":"2023","unstructured":"Mead RJ, Shan N, Reiser HJ et al (2023) Amyotrophic lateral sclerosis: a neurodegenerative disorder poised for successful therapeutic translation. Nat Rev Drug Discov 22:185\u2013212. https:\/\/doi.org\/10.1038\/s41573-022-00612-2","journal-title":"Nat Rev Drug Discov"},{"key":"6265_CR83","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1038\/s41467-017-00911-y","volume":"8","author":"W Guo","year":"2017","unstructured":"Guo W, Naujock M, Fumagalli L et al (2017) HDAC6 inhibition reverses axonal transport defects in motor neurons derived from FUS-ALS patients. Nat Commun 8:861. https:\/\/doi.org\/10.1038\/s41467-017-00911-y","journal-title":"Nat Commun"},{"key":"6265_CR84","doi-asserted-by":"publisher","DOI":"10.1016\/j.nbd.2025.107079","volume":"215","author":"M Bordoni","year":"2025","unstructured":"Bordoni M, Scarian E, Jacchetti E et al (2025) HDAC6 and TDP-43 promote autophagy impairment in amyotrophic lateral sclerosis. Neurobiol Dis 215:107079. https:\/\/doi.org\/10.1016\/j.nbd.2025.107079","journal-title":"Neurobiol Dis"},{"key":"6265_CR85","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2026.178721","volume":"1019","author":"Y Chen","year":"2026","unstructured":"Chen Y, Wu Y, Liu X et al (2026) Bridging protein quality control and epigenetic dysregulation: the HDAC6 paradox in neurological disorders and therapeutic targeting. Eur J Pharmacol 1019:178721. https:\/\/doi.org\/10.1016\/j.ejphar.2026.178721","journal-title":"Eur J Pharmacol"},{"key":"6265_CR86","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1186\/s12931-026-03607-4","volume":"27","author":"Y Li","year":"2026","unstructured":"Li Y, Wang Y, Li W, Yu J (2026) HDAC6 inhibition reprograms endothelial and macrophage responses to protect the lung in endotoxemia. Respir Res 27:210. https:\/\/doi.org\/10.1186\/s12931-026-03607-4","journal-title":"Respir Res"},{"key":"6265_CR87","doi-asserted-by":"publisher","first-page":"2659","DOI":"10.1038\/s41380-022-01511-z","volume":"27","author":"EG Knox","year":"2022","unstructured":"Knox EG, Aburto MR, Clarke G et al (2022) The blood-brain barrier in aging and neurodegeneration. Mol Psychiatry 27:2659\u20132673. https:\/\/doi.org\/10.1038\/s41380-022-01511-z","journal-title":"Mol Psychiatry"},{"key":"6265_CR88","doi-asserted-by":"publisher","unstructured":"Gullotta GS, Costantino G, Sortino MA et al (2023) Microglia and the blood\u2013brain barrier: an external player in acute and chronic neuroinflammatory conditions. Int J Mol Sci 24.https:\/\/doi.org\/10.3390\/ijms24119144","DOI":"10.3390\/ijms24119144"},{"key":"6265_CR89","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-025-96241-x","volume":"15","author":"S Mancino","year":"2025","unstructured":"Mancino S, Boraso M, Galmozzi A et al (2025) Dose-dependent dual effects of HDAC inhibitors on glial inflammatory response. Sci Rep 15:12262. https:\/\/doi.org\/10.1038\/s41598-025-96241-x","journal-title":"Sci Rep"},{"key":"6265_CR90","doi-asserted-by":"publisher","unstructured":"Kim S, Jung UJ, Kim SR, et al (2025) The crucial role of the blood\u2013brain barrier in neurodegenerative diseases: mechanisms of disruption and therapeutic implications. J Clin Med 14. https:\/\/doi.org\/10.3390\/jcm14020386","DOI":"10.3390\/jcm14020386"},{"key":"6265_CR91","doi-asserted-by":"publisher","unstructured":"Shukla S, Tekwani BL (2020) Histone deacetylases inhibitors in neurodegenerative diseases, neuroprotection and neuronal differentiation. Front Pharmacol 11. https:\/\/doi.org\/10.3389\/fphar.2020.00537","DOI":"10.3389\/fphar.2020.00537"},{"key":"6265_CR92","doi-asserted-by":"publisher","DOI":"10.1038\/srep19626","volume":"6","author":"Z Wang","year":"2016","unstructured":"Wang Z, Leng Y, Wang J et al (2016) Tubastatin A, an HDAC6 inhibitor, alleviates stroke-induced brain infarction and functional deficits: potential roles of \u03b1-tubulin acetylation and FGF-21 up-regulation. Sci Rep 6:19626. https:\/\/doi.org\/10.1038\/srep19626","journal-title":"Sci Rep"},{"key":"6265_CR93","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1016\/j.ipha.2023.09.006","volume":"2","author":"M Mursal","year":"2024","unstructured":"Mursal M, Kumar A, Hasan SM et al (2024) Role of natural bioactive compounds in the management of neurodegenerative disorders. Intell Pharm 2:102\u2013113. https:\/\/doi.org\/10.1016\/j.ipha.2023.09.006","journal-title":"Intell Pharm"},{"key":"6265_CR94","doi-asserted-by":"publisher","first-page":"3667","DOI":"10.1021\/acsomega.2c06098","volume":"8","author":"A Babazadeh","year":"2023","unstructured":"Babazadeh A, Vahed FM, Liu Q et al (2023) Natural bioactive molecules as neuromedicines for the treatment\/prevention of neurodegenerative diseases. ACS Omega 8:3667\u20133683. https:\/\/doi.org\/10.1021\/acsomega.2c06098","journal-title":"ACS Omega"},{"key":"6265_CR95","doi-asserted-by":"publisher","DOI":"10.1016\/j.bmc.2021.116510","volume":"52","author":"X Qiu","year":"2021","unstructured":"Qiu X, Zhu L, Wang H et al (2021) From natural products to HDAC inhibitors: an overview of drug discovery and design strategy. Bioorg Med Chem 52:116510. https:\/\/doi.org\/10.1016\/j.bmc.2021.116510","journal-title":"Bioorg Med Chem"},{"key":"6265_CR96","doi-asserted-by":"publisher","DOI":"10.1016\/j.phymed.2025.157495","volume":"148","author":"Q Wu","year":"2025","unstructured":"Wu Q, Xiao C, Ouyang B et al (2025) Unveiling the influence of polyphenols on histone modifications in human diseases. Phytomedicine 148:157495. https:\/\/doi.org\/10.1016\/j.phymed.2025.157495","journal-title":"Phytomedicine"},{"key":"6265_CR97","doi-asserted-by":"publisher","unstructured":"Ferreira C, Vieira P, S\u00e1 H et al (2024) Polyphenols: immunonutrients tipping the balance of immunometabolism in chronic diseases. Front Immunol 15. https:\/\/doi.org\/10.3389\/fimmu.2024.1360065","DOI":"10.3389\/fimmu.2024.1360065"},{"key":"6265_CR98","doi-asserted-by":"publisher","unstructured":"Yang K, Lv Z, Zhao W et al (2024) The potential of natural products to inhibit abnormal aggregation of \u03b1-Synuclein in the treatment of Parkinson\u2019s disease. Front Pharmacol 15. https:\/\/doi.org\/10.3389\/fphar.2024.1468850","DOI":"10.3389\/fphar.2024.1468850"},{"key":"6265_CR99","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2025.123528","volume":"369","author":"Y Wang","year":"2025","unstructured":"Wang Y, Dou W, Qian X et al (2025) Advancements in the study of short-chain fatty acids and their therapeutic effects on atherosclerosis. Life Sci 369:123528. https:\/\/doi.org\/10.1016\/j.lfs.2025.123528","journal-title":"Life Sci"},{"key":"6265_CR100","doi-asserted-by":"publisher","unstructured":"Jalouli M, Rahman MA, Biswas P et al (2025) Targeting natural antioxidant polyphenols to protect neuroinflammation and neurodegenerative diseases: a comprehensive review. Front Pharmacol 16. https:\/\/doi.org\/10.3389\/fphar.2025.1492517","DOI":"10.3389\/fphar.2025.1492517"},{"key":"6265_CR101","doi-asserted-by":"publisher","first-page":"8074","DOI":"10.1074\/jbc.M112.432773","volume":"288","author":"F Schlumm","year":"2013","unstructured":"Schlumm F, Mauceri D, Freitag HE, Bading H (2013) Nuclear calcium signaling regulates nuclear export of a subset of class IIa histone deacetylases following synaptic activity. J Biol Chem 288:8074\u20138084. https:\/\/doi.org\/10.1074\/jbc.M112.432773","journal-title":"J Biol Chem"},{"key":"6265_CR102","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuropharm.2024.110096","volume":"259","author":"AP Kamath","year":"2024","unstructured":"Kamath AP, Nayak PG, John J et al (2024) Revolutionizing neurotherapeutics: nanocarriers unveiling the potential of phytochemicals in Alzheimer\u2019s disease. Neuropharmacology 259:110096. https:\/\/doi.org\/10.1016\/j.neuropharm.2024.110096","journal-title":"Neuropharmacology"},{"key":"6265_CR103","doi-asserted-by":"publisher","unstructured":"Nahar L, Charoensup R, Kalieva K et al (2025) Natural products in neurodegenerative diseases: recent advances and future outlook. Front Pharmacol 16. https:\/\/doi.org\/10.3389\/fphar.2025.1529194","DOI":"10.3389\/fphar.2025.1529194"},{"key":"6265_CR104","doi-asserted-by":"publisher","DOI":"10.1016\/j.mcn.2025.104010","volume":"133","author":"V Bhati","year":"2025","unstructured":"Bhati V, Prasad S, Kabra A (2025) RNA-based therapies for neurodegenerative disease: targeting molecular mechanisms for disease modification. Mol Cell Neurosci 133:104010. https:\/\/doi.org\/10.1016\/j.mcn.2025.104010","journal-title":"Mol Cell Neurosci"},{"key":"6265_CR105","doi-asserted-by":"publisher","first-page":"e1092252025","DOI":"10.1523\/JNEUROSCI.1092-25.2025","volume":"46","author":"A Crowe","year":"2026","unstructured":"Crowe A, Yao Y, Newman M et al (2026) HDAC6 inhibition reduces seeded tau and \u03b1-synuclein pathologies in primary neuron cultures and wild-type mice. J Neurosci 46:e1092252025. https:\/\/doi.org\/10.1523\/JNEUROSCI.1092-25.202","journal-title":"J Neurosci"},{"key":"6265_CR106","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-19317-4","volume":"11","author":"H Trzeciakiewicz","year":"2020","unstructured":"Trzeciakiewicz H, Ajit D, Tseng J-H et al (2020) An HDAC6-dependent surveillance mechanism suppresses tau-mediated neurodegeneration and cognitive decline. Nat Commun 11:5522. https:\/\/doi.org\/10.1038\/s41467-020-19317-4","journal-title":"Nat Commun"},{"key":"6265_CR107","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0054222","volume":"8","author":"A Jovicic","year":"2013","unstructured":"Jovicic A, Jolissaint JFZ, Moser R et al (2013) MicroRNA-22 (miR-22) overexpression is neuroprotective via general anti-apoptotic effects and may also target specific Huntington\u2019s disease-related mechanisms. PLoS ONE 8:e54222. https:\/\/doi.org\/10.1371\/journal.pone.0054222","journal-title":"PLoS ONE"},{"key":"6265_CR108","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.aee7295","volume":"12","author":"BA Van Bree","year":"2026","unstructured":"Van Bree BA, Eichner LJ (2026) The impactful role of the HDACs in the regulation of gene expression and as targets for disease therapy. Sci Adv 12:eaee7295. https:\/\/doi.org\/10.1126\/sciadv.aee7295","journal-title":"Sci Adv"}],"container-title":["Molecular Neurobiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-026-06265-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12035-026-06265-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-026-06265-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T14:02:33Z","timestamp":1792072953000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12035-026-06265-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":108,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["6265"],"URL":"https:\/\/doi.org\/10.1007\/s12035-026-06265-1","relation":{},"ISSN":["0893-7648","1559-1182"],"issn-type":[{"value":"0893-7648","type":"print"},{"value":"1559-1182","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"22 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 October 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 October 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable to this manuscript.","order":1,"name":"Ethics","label":"Ethics Approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All authors read and approved the final manuscript and agree with its publication.","order":2,"name":"Ethics","label":"Consent for Publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":4,"name":"Ethics","label":"Gels and Blots Image(s)","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"965"}}